Other Transaction Agreement 140D042590018
Award Date
5/20/25
Potential Completion Date
5/19/28
Potential Value
$15M
Funding Federal Agency
National Institutes of Health
Contracting Federal Agency
Interior Business Center
Awardee
Dnanexus, Inc.
Ultimate Awardee
Not listed
NAICS Category
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Mountain View, CA 94040, USA
Solicitation Procedures
Program Solicitation
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Dnanexus, Inc. for the procurement of the DnaNexus bioinformatic cloud computing platform license and support. The total potential value of the contract is $120,000.00, and the period of performance will end on September 18, 2024. The contract does not have a set-aside designation. Dnanexus, Inc. will provide cloud-based genomics...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed-price purchase order contract to Dnanexus, Inc. for a "Biobank Research Analysis Platform." The $12,569.50 contract does not have a set-aside designation and is for the delivery of cloud-based genomics data management and analysis services from Dnanexus, a for-profit organization. Through this award, Dnanexus will provide bioinformatics software,...
This is a federal contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit company providing cloud-based genomics data management and analysis services. The contract, titled "A Cloud Platform for Evaluating NGS-Based Diagnostic Test Pipelines," has a ceiling value of $1,993,255.79 and runs through April 27, 2018. The contract is a definitive contract with a firm fixed price pricing type. Dnanexus has previously held other federal contracts with the FDA...
This federal contract award is for the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists. The $3,132,275.15 firm fixed price delivery order was awarded to Dnanexus, Inc., a for-profit company based in Mountain View, California that specializes in cloud-based genomics data management and analysis services. This contract supports critical initiatives in precision medicine,...
The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...
The National Cancer Institute (NCI) has awarded a $667,500.00 firm-fixed-price purchase order to Dnanexus, Inc. for a Platform as a Service (PaaS) solution to support the Confluence Project. The contract has a period of performance through September 8, 2027. Dnanexus is the sole provider of a commercially available cloud PaaS solution that meets the computational, security, and regulatory requirements necessary for this effort, including FedRAMP Moderate certification and compliance with...
This is a $1,051,402.26 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. for the development of a PRISM high-impact platform pilot to support pre-submission validation of electronic common technical documents (eCTDs) and sponsor-reviewer interaction. The contract has an ultimate completion date of September 9, 2025. Dnanexus is a for-profit cloud-based genomics data management and analysis services provider that has previously supported the...
This firm-fixed-price delivery order for $631,840.53 was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The award is for Phase III of the FY24 Common Data Harmonization System, a project to develop and maintain cloud-based platforms that support collaboration between researchers and regulatory reviewers, as well as genomic data analysis environments. Dnanexus has...
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported...
Dnanexus, Inc. was awarded a firm fixed price delivery order valued at one hundred ninety-four thousand five hundred ninety-eight dollars and thirteen cents ($194,598.13) by the Department of Health and Human Services' Food and Drug Administration (FDA). This delivery order, with a period of performance through September 2023 and no set-aside designation, is issued against Dnanexus' twenty million dollar ($20M) indefinite delivery contract for ongoing provision of the FDA's PrecisionFDA...